R&D Tax Credit Schemes Explained: SME, RDEC, Merged Scheme & ERIS

A complete guide to UK R&D tax credit rates, scheme eligibility and the changes from April 2024

Read time
5 minutes

The UK's R&D tax credit landscape has changed significantly over the past few years. The introduction of the R&D merged scheme and the Enhanced R&D Intensive Support (ERIS) scheme from April 2024 replaced the long-standing dual system, bringing SMEs and large companies under one framework for the first time. Understanding which scheme applies to your business, and what relief rate you can now claim, is essential to successfully submitting an R&D claim.  

‍

This guide walks through the history of the schemes, the current relief rates available, and exactly who qualifies to claim under the merged and ERIS schemes.

‍

From SME R&D tax credits and RDEC to the R&D Merged Scheme

‍

For over two decades, UK businesses have claimed R&D tax relief through one of two routes: the SME R&D tax relief scheme or the Research and Development Expenditure Credit (RDEC) scheme. The applicable scheme that a Company had traditionally used was dependent on the size of business from both a turnover and employee threshold.

‍

How R&D tax credits used to work

SME R&D tax relief

SME R&D Tax Relief was introduced to help smaller businesses invest in research and development. At its most generous, the relief was worth up to 33% of qualifying R&D expenditure.

From 1 April 2023, the rates were reduced, and capped at a limit of 21.5%. However, businesses that spent at least 40% of their total costs on qualifying R&D remained eligible for an enhanced rate, and could claim up to 27% relief.

‍

RDEC rates and scheme overview

RDEC was aimed at large companies, and at SMEs whose R&D activities were subsidised or carried out on behalf of another organisation. It worked differently to the SME scheme: the credit was treated as taxable income ("above the line credit"), making the benefit more visible in reported profits. From April 2023, net benefit increased from 10.5% after tax to up to 16.2% of eligible costs, making the scheme significantly more generous.

‍

The 2024 Reform: The merged R&D Scheme and ERIS scheme

From 1 April 2024, HMRC replaced the previous SME/RDEC scheme structure with a single merged R&D scheme, alongside a targeted support route for loss-making R&D-intensive SMEs known as the Enhanced R&D Intensive Support (ERIS) scheme.

‍

The merged R&D scheme

The merged R&D scheme is broadly based on the RDEC model, meaning R&D relief is delivered as an above-the-line credit, regardless of company size. This is a significant structural shift for businesses that previously claimed under the SME scheme.

The majority of UK companies undertaking qualifying R&D now claim through the merged scheme.

‍

The ERIS R&D scheme (Enhanced R&D Intensive Support)

The ERIS scheme is a higher-rate route for qualifying loss-making SMEs that are heavily investing in R&D, otherwise known as 'R&D intensive.' It was introduced to ensure that innovation-intensive small businesses weren't negatively affected by the move away from the old SME scheme's more generous rates and to provide additional support to these companies.  

To access the enhanced R&D intensive support rate, a company must be loss-making and meet an R&D intensity threshold: meaning a significant proportion of their total spend must fall under qualifying R&D activity.

‍

R&D tax credit relief rates: Merged and ERIS vs older schemes

‍

The table below sets out the relief values across the main R&D schemes, as well as the accounting period to which they apply/applied.

‍

Scheme Period Who It Applied To Net Benefit
SME R&D Tax Relief (profit-making) Pre-April 2023 SMEs in profit Up to ~25% of qualifying spend
SME R&D Tax Relief (profit-making) April 2023 – March 2024 SMEs in profit ~21.5% of qualifying spend
SME R&D Tax Relief (loss-making, standard) Pre-April 2023 Loss-making SMEs Up to ~33% of qualifying spend
SME R&D Tax Relief (loss-making, standard) April 2023 – March 2024 Loss-making SMEs Up to ~18.6% of qualifying spend
SME R&D Tax Relief (loss-making, intensive) April 2023 – March 2024 Loss-making SMEs spending ≥40% on R&D Up to ~27% of qualifying spend
RDEC Pre-April 2023 Large companies & certain SMEs ~10.5% net
RDEC April 2023 – March 2024 Large companies & certain SMEs Up to 16.2% net
R&D Merged Scheme From April 2024 All companies (default) ~15% net (25% CT)
~16.2% net (19% CT)
ERIS From April 2024 Loss-making SMEs spending ≥30% on R&D Up to ~27% of qualifying spend

‍

The net benefit under the merged scheme depends on the corporation tax rate applicable to your business. At the main 25% corporation tax rate, the next benefit rate is approximately 15%; at the small profits rate of 19%, it is approximately 16.2%.

‍

Understanding what scheme your business is eligible for

‍

How has eligibility changed from the old schemes?

The shift from SME and RDEC to merged and ERIS has had implications on eligibility as well as rates and benefits. Below are some of the ways eligibility has changed:

‍

Size is no longer the primary dividing line

Under the old system, being an SME or a large company determined which scheme you fell under, almost automatically (due to employee and turnover thresholds). Under the new system, most companies, whatever their size, will claim under the merged scheme.

‍

The contracted R&D rules have changed significantly

Under the old SME scheme, companies could claim even where R&D was undertaken on their behalf (i.e. as a subcontractor). The merged scheme shifts this: the company commissioning the R&D is generally eligible for relief, not the company doing the work.

‍

The R&D intensity test is new

There was no equivalent to the ERIS intensity threshold under the old SME scheme. Any qualifying SME could access the higher rates regardless of how R&D-heavy their business was. The ERIS scheme is more targeted, offering preferential rates to the SME companies who most need the support.

‍

Who qualifies for the merged scheme

The merged scheme applies to most UK-incorporated companies that are subject to corporation tax and are carrying out qualifying R&D activities. The key eligibility criteria are:

‍

  • UK limited company: partnerships, sole traders and non-UK resident companies are not eligible
  • R&D meets HMRC’s definition: project seeks to achieve an advance in overall knowledge or capability in science or technology, with genuine scientific or technological uncertainty involved, that was not readily deductible by a competent professional within the field Read more about how HMRC defines R&D in our ultimate guide.
  • Costs must be qualifying expenditure: staffing costs, subcontractor costs, consumables, software, externally provided workers. Read more about qualifying expenditure here.

‍

In terms of previous scheme eligibility, the merged scheme applies to:

  • Large companies that previously claimed under RDEC
  • Profit-making SMEs that previously claimed under the SME scheme
  • Loss-making SMEs that do not meet the ERIS intensity threshold

‍

Who qualifies for the ERIS scheme

To qualify for the Enhanced R&D Intensive Support scheme, a company must meet all of the following conditions:

‍

  • Operate as an SME: a company with fewer than 500 employees and either an annual turnover not exceeding £100 million or a balance sheet not exceeding £86 million.
  • Be loss-making: the company must have a trading loss before being eligible to claim under the ERIS scheme. 
  • Meet the R&D intensity threshold: at least 30% of the company's total expenditure must be qualifying R&D expenditure. This threshold was lowered from 40% (which applied from April 2023 to March 2024), bringing an estimated 5,000 additional companies into the scheme
  • The R&D must meet standard qualifying criteria: the same rules around scientific/technological advance and uncertainty apply.

There’s also a one-year grace period for companies that dip below the 30% intensity threshold. This prevents businesses being moved in and out of the enhanced rate, which would otherwise create significant financial planning challenges for R&D-heavy businesses operating near the boundary. If you’re unsure whether this scheme applies to you, speak to one of our advisors for a free audit of your R&D tax status.

‍

‍

The importance of working with an R&D specialist to identify the right scheme and relief

‍

The April 2024 reforms didn't just change the rates, they changed how eligibility works, which costs qualify, and which scheme a business should be claiming under. For companies that have been claiming R&D tax relief for years, the assumption that the same approach will continue to work is one of the more common, and costly mistakes. This is why it’s more important than ever to work with a qualified R&D tax specialist and to seek expert advice.

‍

If you have questions about whether you meet the ERIS intensity threshold, how to identify relevant costs, and which scheme you qualify for, contact one of our specialists for a free audit.

‍

‍

FAQs

What are the current R&D tax credit relief rates

Under the merged R&D scheme, businesses can claim up to ~16% net benefit on qualifying R&D spend depending on how much corporation tax you pay. Under the ERIS scheme, eligible companies can claim a payable credit of 27% of qualifying R&D expenditure.

‍

What is ERIS in R&D tax?

ERIS stands for Enhanced R&D Intensive Support. It is an enhanced-rate R&D credit route available to loss-making SMEs that spend at least 30% of their total relevant expenditure on qualifying R&D. The ERIS scheme pays a credit of 27%, making it significantly more valuable than the standard rate for those who companies qualify.

‍

Can I still claim under the SME R&D tax credit scheme?

The SME R&D tax credit scheme closed to new claims for accounting periods starting on or after 1 April 2024. If your accounting period began before that date, the old SME rules may still apply. For periods starting from April 2024 onwards, you will need to claim under either the merged R&D scheme or the ERIS scheme.

‍

How do I know if I qualify for the ERIS scheme?

To access ERIS, your company must be an SME (fewer than 500 employees and within the turnover/balance sheet thresholds), be loss-making in the relevant period, and have qualifying R&D costs that represent at least 30% of total relevant expenditure. If you're unsure whether you meet the intensity threshold, contact us for a free audit of your R&D tax status.

Explore other articles

R&D Tax Credit claim notification to end in April 2027

The government has announced that the R&D Claim Notification Form (CNF) requirement will be removed for claims made from 1 April 2027, subject to legislation. Find out what is changing, when the new rules take effect and what companies need to do in the meantime.

November 3, 2026
4 minutes

2026 Budget Summary

Chancellor John Healey’s 2026 Budget introduced several significant measures for UK businesses, including changes to R&D tax relief, energy reliefs and capital allowances. Key announcements include the removal of the R&D Claim Notification Form, plans to simplify the Additional Information Form, further support for energy-intensive businesses and changes to the Capital Allowances regime rates. We summarise the key developments and what they could mean for businesses.

October 28, 2026
4 minutes

'Creating Value as a CFO', by Jitesh Sodha, member of RCK’s Innovation Advisory Council

In this article, Jitesh Sodha, an advisor on our Innovation Advisory Council, draws on nearly 30 years of experience as a CFO to explore how finance leaders can create long-term value by shaping strategy, supporting better decision-making and focusing on people, cash and technology.

September 7, 2026
6 minutes

Book your free audit